Get started
Author

Chenhan Zhong

Observed names: Chen-Han Zhong, Zhong Chenhan
ORCID: 0000-0002-7138-5046
Observed ORCID: 0000-0002-7138-5046
OpenAlex ID: A5000951995
A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing
2017 · Lizhen Zhu, Yanqin Huang, et al. · Journal of Molecular Diagnostics · 127
PDF
Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness
2021 · Kai Jiang, Haiyan Chen, et al. · Journal of Experimental & Clinical Cancer Research · 124
PDF
Genetic and metabolic links between the murine microbiome and memory
2020 · Jian-Hua Mao, Young-Mo Kim, et al. · Microbiome · 108
PDF
Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach
2017 · Jiekai Yu, Xiaohui Zhai, et al. · Scientific Reports · 57
PDF
Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer
2020 · Dan Li, Shanshan Weng, et al. · Frontiers in Oncology · 40
PDF
High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers
2016 · Jiekai Yu, Xiaofen Li, et al. · Oncotarget · 40
PDF
Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial
2023 · Xuefeng Fang, Ning Zhu, et al. · EClinicalMedicine · 36
PDF
Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
2016 · Lizhen Zhu, Caixia Dong, et al. · PLoS ONE · 31
PDF
Zyxin as a potential cancer prognostic marker promotes the proliferation and metastasis of colorectal cancer cells
2019 · Chenhan Zhong, Jiekai Yu, et al. · Journal of Cellular Physiology · 24
The clinicopathological features and prognostic factors of gastric squamous cell carcinoma
2016 · Caixia Dong, Mengjie Jiang, et al. · Medicine · 23
A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer
2019 · Dan Li, Chenhan Zhong, et al. · Journal of Cancer · 22
PDF
Identification of Kininogen 1 as a Serum Protein Marker of Colorectal Adenoma in Patients with a Family History of Colorectal Cancer
2018 · Jiekai Yu, Yanqin Huang, et al. · Journal of Cancer · 20
PDF
Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death
2019 · Jianfei Fu, Chenhan Zhong, et al. · Journal of Breast Cancer · 18
PDF
Host genetics and gut microbiota cooperatively contribute to azoxymethane-induced acute toxicity in Collaborative Cross mice
2021 · Chenhan Zhong, Li He, et al. · Archives of Toxicology · 16
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study
2023 · Xuefeng Fang, Chenhan Zhong, et al. · BMC Cancer · 15
PDF
A phase 2 trial of sintilimab (IBI 308) in combination with CAPEOX and bevacizumab (BBCAPX) as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer.
2022 · Xuefeng Fang, Chenhan Zhong, et al. · Journal of Clinical Oncology · 14
Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy
2018 · Dan Li, Chenhan Zhong, et al. · Journal of Cancer Research and Clinical Oncology · 14
Correction to: Genetic and metabolic links between the murine microbiome and memory
2020 · Jian-Hua Mao, Young-Mo Kim, et al. · Microbiome · 9
PDF
Report of two cases and a systematic review of breast cancer with gastrointestinal metastasis
2019 · Chenhan Zhong, Xuefeng Fang, et al. · The Turkish Journal of Gastroenterology · 6
PDF
Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer
2024 · Dan Li, Chenhan Zhong, et al. · Gut Microbes · 5
PDF
Genetic architecture of the acute and persistent immune cell response after radiation exposure
2023 · Li He, Chenhan Zhong, et al. · Cell Genomics · 5
PDF
Updated results and biomarker analyses from the phase 2 trial (BBCAPX study) of sintilimab plus bevacizumab and CapeOx as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer.
2023 · Ying Yuan, Xuefeng Fang, et al. · Journal of Clinical Oncology · 4
Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
2017 · Xiao-Fen Li, Yi-Nuo Tan, et al. · Oncotarget · 3
PDF
Discovery, identification and mechanism of chemosensitivity-relate biomarker inter-α-trypsin inhibitor heavy chain 4 in metastatic colorectal cancer
2024 · Yingxin Zhao, Hong Shen, et al. · Heliyon · 2
Updated survival results of BBCAPX-II: Sintilimab combined with bevacizumab and CapeOx as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer.
2024 · Ying Yuan, Ning Zhu, et al. · Journal of Clinical Oncology · 2
PDF
Works count: 37
Citation count: 773
H-index: 15
I10-index: 17
Year
Topic
Type